Learn details on Non-Alcoholic Steatohepatitis pipeline (NASH) drugs therapeutics development by by companies and universities/research institutes.The report reviews key players involved AdAlta Ltd, Albireo Pharma Inc, Allergan Plc, Alnylam Pharmaceuticals Inc, Amunix Operating Inc, Aquinox Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ardelyx Inc, AstraZeneca Plc, Betagenon AB, BioLineRx Ltd, Bird Rock Bio Inc, BLR Bio LLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Can-Fite BioPharma Ltd, Cardax Inc, Carmot Therapeutics Inc, Catabasis Pharmaceuticals Inc, Cerenis Therapeutics Holding SA, ChemoCentryx Inc, CohBar Inc, Conatus Pharmaceuticals Inc, Connexios Life Sciences Pvt Ltd, ConSynance Therapeutics Inc, CymaBay Therapeutics Inc, Daiichi Sankyo Company Ltd, Dimerix Bioscience Pty Ltd, Dong-A Socio Holdings Co Ltd and more..
Non Alcoholic Steatohepatitis Pipeline (NASH) Review, H2 2017, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline landscape. Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarring of the liver, which leads to cirrhosis. Symptoms of NASH include fatigue, weight loss for no clear reason, general weakness and an ache in the upper right part of belly. Risk factors include obesity, type 2 diabetes, high cholesterol and high triglycerides and metabolic syndrome.
Purchase This Single User License PDF Report of 446 pages at: http://www.reportsnreports.com/purchase.aspx?name=1125834
The Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 28, 27, 3, 75, 28 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Discount is available on Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) report at http://www.reportsnreports.com/contacts/discount.aspx?name=1125834
List of Figures
Number of Products under Development for Non-Alcoholic Steatohepatitis (NASH), H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017
ReportsandReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441